Adcytherix is a verifiable biopharmaceutical company that raised ~€105M ($122M) in Series A funding (Oct 2025) to develop Antibody-Drug Conjugates (ADCs). The project demonstrates exceptional real-world utility and technical innovation in oncology. However, the submission itself contains significant inaccuracies (e.g., claiming 'team size 0' and 'everyone' as the audience) and appears to be created by a third party ('AncientRider') rather than the company. The score reflects the high intrinsic value of the technology and verified financial traction, heavily penalized for the poor quality of the submission data and false reach claims.
Ready to Compete for $150k+ in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline